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The molecular weight, subunit properties and secondary structure
of purified mouse placental alkaline phosphatase (APase) were investi¬
gated. This project was conducted in an effort to determine whether or
not the characteristics of mouse placental APase were similar enough to
those of various tumor-associated APases found in other animals such
that the mouse system might be used as a model system in which to study
the role of embryonic functions in malignant cells.
The final procedures in the purification of APase consisted of
chromatography on Sephadex G-200 and DEAE-cellulose. The subunit
structure and molecular weight were determined by SDS acrylamide gel
electrophoresis and gel filtration. The technique of circular
dichroism (CD) was employed in the investigation of the secondary
structure.
The results obtained in this study indicate that mouse placental
APase has a molecular weight of approximately 170,000 d. The monomer
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activity. The CD studies indicate that the mouse placental APase molecule
consisted of less than 10% a-helix, approximately 20% B-pleated sheet
and 70% random coil structure.
Therefore, we have concluded that, in consideration of the data reported
here on the mouse placental APase and elsewhere on tiunor-associated
APases, the mouse system can be used as a model system in which to
study embryonic functions in malignant transformation.
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CHAPTER I
INTRODUCTION
Alkaline phosphatases catalyze the hydrolysis of almost any
phosphomonoester to give inorganic phosphate (Pi) and the corresponding
alcohol, phenol or sugar. They are distinguished from a similar group
of enzymes, the acid phosphatases, basically by their dependence on a
high or alkaline pH for catalytic activity. Biochemical characteriza¬
tions of certain alkaline phosphatases (APases) have resulted in their
being associated with viral- and chemically-induced thymic lymphomas.
Histochemical studies have shown that the APase in mouse lymphomas is
located on the cell membrane (Lagerlof and Kaplan, 1967). In the
placenta, APases are characteristically present in the trophoblastic
syncytium, a tissue involved in the transport of nutrients (Wachstein
et al., 1963).
Immunochemical and various kinds of chromatographic techniques
have shown that there are biochemical and biophysical differences between
species APases and also tissue APases (Sussman et al., 1968). Moss
(1970) demonstrated the heterogeneity of human APases using bone, liver,
placenta, and intestine as the source of enzyme.
The biophysical nature of the human placental APase has not been
as thoroughly investigated as the APase of Escherichia coli. However, it
has been purified by Harkness (1968a),Sussman et al. (1968), Ghosh (1969),
and Doellgast and Fishman (1974). Molecular weights ranging from 116,000
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(Gottlieb and Sussman, 1968) to 200,000 (Ghosh, 1969) have been
reported. Sussman and Gottlieb (1969) have shown the human placental
APase to be a dimer with subunits of equal molecular weights. They also
compared the conformations of the monomer and the dimer.
A number of reports has shown that the human placental APase is
similar to, but not identical with the tumor-associated alkaline phospha¬
tases. Much of these data have come from biochemical and immunological
studies on the enzyme. A somewhat neglected area of investigation is
that of a more inclusive biophysical characterization of the placental
APase. The spectropolarimeter is a very valuable instrument for deter¬
mining such characteristics. Employing the technique of circular
dichroism (CD), one is able to investigate the conformation of molecules
while they are in solution.
Although the molecular weight and subunit properties of the human
placental APase have been reported, little if any data of this kind are
available on the mouse placental enzyme. In this investigation an
attempt has been made to determine some of the physicochemical charac¬
teristics of the mouse placenta APase. These included the molecular
weight and subunit properties and an investigation of the secondary
structure. In addition, these properties are compared with those
reported for the human placental APase and other tumor-associated APases
for the purpose of showing similarities of one APase to the other. If
the mouse APase can be shown to be similar or identical, then this
system could be used as a model in which to study the role of embryonic
functions in malignant cells.
CHAPTER II
REVIEW OF LITERATURE
Characteristics of Alkaline Phosphatases
Alkaline phosphatases are a group of non-specific enzymes that
catalyze the hydrolysis of a large variety of phosphomonoesterases.
Recently a number of investigators have devoted a great deal of time and
effort toward the study of these enzymes in many different organisms
ranging from bacteria to various organs of humans.
By far the most extensively studied and characterized alkaline
phosphatase (APase) is that of Escherichia coli. Malamy and Horecker
(1964) showed this APase to be localized in the periplasmic space, a
region lying between the protoplasmic membrane and the cell wall.
Alkaline phosphatase is relatively abundant in fishes (Bodansky et al.,
1931). In mammals, APase has been studied in a number of tissues.
Some of these tissues include the intestinal mucosa, placenta, kidney,
bone, liver, lung and spleen (Macfarlane et al., 1934; Kay, 1932).
Folley and Kay (1935) also showed that guinea pig mammary gland was
another organ rich in APase. The distribution of this enzyme within
a particular tissue varies. Kay (1928) showed that the kidney cortex
contained much more APase than the medulla. Using histochemical
techniques, Clark (1961) and Ito (1969) have shown that the intestinal
enzyme is located primarily at the surface membrane of the epithelial
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cell microvilli. In the placenta the APase is located at the surface
of the trophoblastic syncytium (Wachstein et al., 1963).
Although a precise function has not been determined for any
alkaline phosphatase, generally one can say that it is abundant in those
tissues which are actively engaged in transport of nutrients. It is
also frequently found in secretory organs and developing tissues.
Most alkaline phosphatases are stable at room temperature. They
become less stable as their purity is increased. They are very non¬
specific in that they will catalyze a variety of substrates including
glucose-1-phosphate, 3-glycerophosphate, p-nitrophenyl phosphate, and
many others (Harkness, 1968b).
Although most of the mammalian APases have been shown to be
zinc metallo-enzymes, various other divalent cations have been shown
to activate these enzymes. These include cobalt, magnesium, and
manganese (Ahmed and King, 1960; Portmann, 1957; Morton, 1955). Other
ions such as beryllium and zinc have been found to be inhibitory.
Circular Dichroism
Theory
Investigations into the secondary, tertiary and quarternary
structure of molecules have been severely limited previously because of
the difficulty in observing such structures. With the technique of
circular dichroism (CD) one can now investigate such structures as well
as changes in these structures that might occur as a result of changes
in the molecular environment.
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The basic operational principle of the spectropolarimeter is
that light from a xenon lamp passes through a monochromator and is then
linearly polarized as it passes through a Rochon polarizing prism. The
linearly polarized light then enters a Pockels cell with the emergent
light being alternately left- and right- circularly polarized. When
circularly polarized light is passed through an optically active sample,
unequal absorption of the left and right circular components occurs.
The emergent light, due to unequal absorption, is then elliptically
polarized. Actually, the difference in absorbance of the two circularly
polarized components is measured directly by the spectropolarimeter.
The molar ellipticity (0) is related to the difference in absorbance by
6=2.303 180 (At - A )
4Tr 1 r
=33.00 (A. - A )1 r
where A^ and A^ are the absorbances for the left- and right-circularly
polarized light, respectively.
There are certain chromophores which account for the CD of proteins.
These are the peptide bonds, disulfide bridges, and the side chains of
the aromatic amino acids of phenylalanine, tryosine and tryptophan.
Application to alkaline phosphatase
Reynolds and Schlesinger (1969) applied CD in their study of the
refolding and reassociation of subunits of coli APase resulting from
changes in pH. They found that below pH 4 the _E. coli APase molecule
undergoes a radical change in conformation. Applebury and Coleman (1969)
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performed basically the same experiments and obtained similar results.
They suggested that this change in conformation was associated with
the dissociation of the molecule into subunits.
Various agents such as 2-mercaptoethanol, guanidine hydrochloride
and urea are known to denature protein. Trotman and Greenwood (1971)
investigated the changes in coli APase that occurred due to the
presence of varying concentrations of urea. They reported that with urea
concentrations from 3-8 M, a progressive spectral change occurred and
a negative extremum developed at or below 203 nm, indicating that the
enzyme was now in a random-coil formation.
Molecular Weight and Subunit Properties
Molecular weights for alkaline phosphatases have been reported
that range from 190,000 daltons (d) for milk (Barman and Gutfreund, 1966) to
72,000 d in synovial fluid (Dabich and Neuhaus, 1966). The coli APase
has been shown to have a molecular weight of 86,000 with two identical sub¬
units, each with a molecular of 43,000 d (Garen and Levinthal, 1960;
Schlesinger et al., 1969). Levinthal et al. (1962) also reported that
this enzyme could be reversibly denatured by thiol reduction in the
presence of urea which dissociates the dimer into monomers.
An APase in Neurospora crassa has been isolated and characterized
by Kadner et al. (1968). They reported that the native enzyme had a
molecular weight of 154,000 d and that it consisted of two subunits with
molecular weights of 77,000 d each. Their determination of the amino
acid and sugar composition of this enzyme disclosed that it was a glyco¬
protein in which carbohydrate constituted 11.5% of the total weight.
The human placental APase is thought to be a dimer with subunits
of equal molecular weights. Gottlieb and Sussman (1968) in their
investigation of the molecular weight and subunit structure of this
enzyme reported its molecular weight to be 116,000 d. Each of the
monomer subunits has identical molecular weight of 58,000 d. According to
Robson and Harris (1967) there are three common types of subunits
found in the human placenta which can combine to give six electro-
phoretically distinguishable variants. No such genetic variation has
been found with any other tissue alkaline phosphatases according to
these investigators.
Purification of Alkaline Phosphatase
The methods for purifying coli alkaline phosphatase have been
extensively reviewed by Torriani (1968). One of the earliest methods
involved heat shock (Garen and Levinthal, 1960). By growing coli
in phenyl phosphate, they could induce a high level of APase production.
This method was followed by one consisting of the disruption of cells
with a French press (Garen and Echols, 1962) and the preparation of
acetone powders (Plocke et al., 1962). Escherichia coli APase was
first purified to a crystalline form by Malamy and Horecker (1964)
using ammonium sulfate precipitation.
Numerous methods for the extraction and purification of various
tissue phosphatases have appeared in the literature recently. The
htiman placental APase is one of the most highly purified preparations of
them all. Ghosh and Fishman (1968) and Harkness (1968a) were both
successful in obtaining this enzyme in a crystalline form.
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The enzyme is normally firmly bound to lipo-protein membranes
but it can be solubilized by treating it with n-butanol. This includes
mincing or grinding it, followed by stirring with an excess amount of
the alcohol for approximately 30 min in the cold. After this step,
various procedures for further purification have been employed to obtain
a higher degree of purification.
After extraction with butanol, Greene and Sussman (1973) precipi¬
tated the enzyme with 60% acetone and chromatographed the solubilized
pellet on DEAE-cellulose in Tris-HCl at pH 7.4 with a linear salt
gradient from 0.03 - 0.12 N NaCl. Those fractions having the highest
specific activity were further purified on Sephadex G-200. Harkness
(1968a) was successful in purifying human placental APase to a
crystalline form. After butanol extraction he used ammonium sulfate
precipitation, DEAE-cellulose and ammonium sulfate precipitation again
in order to obtain the enzyme in its highest state of purity.
Two of the less conventional and possibly more efficient methods
of purifying the placental enzyme have been employed by Doellgast and
Fishman (1974) and Gomez et al. (1974). The former investigators
used the technique of affinity chromatography and were able to obtain
a 1000-fold purification with a 22% yield. Although the yield is
slightly less than that reported by Harkness (1968a), the process requires
much less time. Isoelectric focusing was the purification method used
by Gomez et al. (1974). Following DEAE-cellulose column chromatography,
the APase was placed on an LKB electrofocusing column. With this technique
the investigators were able to obtain a fold purification of 106.5.
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The yield, however, was only 11%, which is one-half the yield obtained
by Doellgast and Fishman (1974).
Neoplastic-Associated Alkaline Phosphatases
Alkaline phosphatases have frequently been associated with human
neoplasms. Based on biochemical and immunochemical studies, some of
these APases such as that of HeLa cells and the Regan isoenz3nne, have
been shown to be very similar to the human placental APase. Tan and
Aw (1971), in their studies with HeLa cells, a cell line that originated
from a cervical carcinoma, revealed five isoenzymes by agar gel
electrophoresis. All of these isoenzymes appeared to be neuraminidase-
sensitive. Two were heat-stable at 56 C for 2 hr; had a pH optimum of
10.4, and were inhibited 80% by L-phenylalanine. These characteristics
are all very similar to those of the human placental APase. Fishman et
al. (1968) demonstrated earlier that these cells, HeLa strain, when
growing in tissue culture, exhibit a heat-stable, L-phenylalanine-
sensitive alkaline phosphatase with an electrophoretic mobility similar
to that of the placental APase. These investigators also compared
the immunological similarities of human placental and HeLa phosphatase
isoenzymes to an abnormal phosphatase, the Regan isoenzyme. The latter
isoenzyme, which was first discovered in the sera of a number of cancer
patients, was found to be like the human placental isoenzyme of APase
with respect to L-phenylalanine-sensitivity, heat stability, cleavage by
neuraminidase and starch gel electrophoretic pattern. Fishman (1969)
reported that the biochemical and immunological profiles of the inter¬
action between Regan isoenzyme and antisera to placental APase were
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indistinguishable from the Interaction of the same antibody with
molecular variant B (Ghosh, 1969).
In addition to the biochemical parameters reported by Fishman
(1969) on the similarities of the Regan and placental isoenzyme, other
biochemical studies consisted of a comparison of the Michaelis constants,
inhibition patterns by p-hydroxymercuribenzoate, and kinetic experiments
where urea was a part of the reaction mixture (Fishman et al., 1968).
Differences in the two isoenzymes were found only in the latter set of
experiments. In the experiments, the Regan isoenzyme showed a greater
sensitivity to urea than the placental isoenzyme. It was suggested
by the investigators that this difference could be due to differences in
the three-dimensional structures of the two isoenzymes. These findings
provided evidence and suggested that the Regan isoenzyme and various
other tumor-associated alkaline phosphatases are products of the same
gene as the placental alkaline phosphatase.
Other investigators have compared normal placental APase with the
APases associated with neoplasms. Greene and Sussman (1973) did a
comparative study of normal placental APase and an APase which was
purified from liver metastases of a giant-cell carcinoma of the lung.
They found the two APases to be similar with regard to NH2-termlnal
sequence, peptide map, subunit molecular weight and isoelectric point.
Also, the tumor APase eluted from a Sephadex G-200 column at the same
volume as the placental APase, suggesting that it, like the placental
APase, has a molecular weight of about 120,000 d.
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In addition to studies which show the similarity of tumor-
associated APases and human placental APase, comparisons have also been
made between the placental APases of various mammals. Posen (1969)
showed that the heat resistance of placental APase appears to be
species-specific in that all the non-human placental APases examined
(rat, mouse, rabbit, guinea pig, sheep and horse) were denatured to
varying degrees at 56 C. Leroux and Perry (1971) reported similar findings
in their study of placental APase of various mammals. They found the
mouse placental APase to be heat-labile and that of the human to be
heat-stable. Neumann et al. (1971), in their study on normal and leukemic
mouse thymuses, kidneys, spleens and livers, and Tisdale (1974), in a
study of the mouse placenta, reported that APase in all tissues studied
were heat-labile.
Although most of the evidence reported points out the close
resemblance of the placental and the tumor-associated APases, some
differences have been found. Nakayama et al. (1970) were first to
find a heat-stable alkaline phosphatase distinct from placental
APase or the Regan isoenzyme. This APase was found in a patient with
pleuritis carcinomatosa. Although this isoenzyme and the placental
APase were identical in terms of heat-stability, electrophoretic mo¬
bility, immunological properties and sensitivity to urea, they were
different in their sensitivity to L-leucine and EDTA and in the kinetic
parameters studied. These investigators proposed that this enzyme be
called the Nagao isoenzyme, according to the name of the patient.
Jacoby and Bagshawe (1971) found a tumor-associated APase that was less
12
heat-stable at pH 11 and more sensitive to L-leucine and EDTA than the
placental enzyme.
Several parameters have been used to compare murine thymic
l3rmphoma APase with that of the normal adult mouse placenta. Tisdale
(1974) showed that there was no significant difference between the two
APases with respect to pH optimum, heat inactivation and substrate
specificity. Prioleau (1974) and Khwaja (1974) also reported no
differences between placental and lymphoma APases with respect to
transphosphorylase activity and EDTA inhibition and magnesium activation.
Using acrylamide gel electrophoresis, Floyd (1973) demonstrated that
both enz3nnes were sensitive to neuraminidase. These findings clearly
show that the murine thymic lymphoma and placental APases are indeed
very similar. More importantly, when the same parameters such as pH
optim\im, substrate specificity, neuraminidase-sensitivity and others
are investigated in the human placental and certain types of tumor
APases, the same kinds of similarities are found. This suggests that
the mouse system is analogous to that of humans and that the former may




The alkaline phosphatase (APase) used in this study was obtained
from the placenta of 16-day pregnant C57BL/K mice that were maintained
by brother-sister mating. This inbred strain originally came from
Dr. Henry Kaplan at Stanford University.
Enzyme Assay
The reaction volume was 1 ml and consisted of 1.0 M diethanolamine
(DEA), 5 mM MgCl2, 3.38 mM para-Nitrophenyl phosphate (p-NPP), and
the APase. The initial rate of hydrolysis of p-NPP was measured at
37 C with a Hitachi Digital Spectrophotometer Model 102 equipped with
an N-23 Kinetic Timer and an N-25 sampler/temperature controller. One
unit of enzyme is defined as that amount which liberates 1.0 nMole of
p-nitrophenyl phosphate in 1.0 M DEA containing 5 mM MgCl^, pH 10, at
37 C. The specific activity is expressed as units per mg of protein.
Measurement of Protein
Protein determinations were done according to the method of Lowry
et al. (1951) and by the method of Murphy and Kies (1960), when necessary.
The latter method is based on peptide bond absorption which occurs in
the 195-225 nm region. Absorbance was measured with a Cary 17 Spectro¬
photometer. The protein concentration was determined by the absorbance
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of the protein at 215 and 225 nm and is calculated according to the fol¬
lowing equation.
mg protein per ml = ^215 ~ '^225 ^
Purification Scheme
Tissue homogenization
Placentas were minced in 0.05 M Tris- HCl at pH 7.4 which contained
0.15 M NaCl in order to make a cell suspension. The final preparation
consisted of approximately 1 ml of buffer per placenta. This suspension
was centrifuged at 49,000 rpm for 1 hr at 4 C. The residue was
homogenized in 1% NP-40, incubated at 45 C for 30 min and again centri¬
fuged. This step was repeated three times. Each time the supernatant
was saved for further treatment.
Butanol extraction
The supernatants were pooled and extracted with cold 30% (v/v)
n-butanol. The butanol was added slowly with stirring until the desired
concentration was reached. After 30 min of stirring at 4 C, the
preparation was centrifuged for 1 hr at 49,000 rpm. Afterwards, the
aqueous layer, which contained the enzyme, was removed and dialyzed
against glass-distilled water for approximately 36 hr with frequent
changes. The enzyme preparation was then concentrated and frozen at
-18 C until ready for application to the DEAE-cellulose column.
DEAE-cellulose and sephadex G-200 column chromatography
The placental APase was further purified following butanol
extraction by ion-exchange and gel filtration chromatography. All
chromatographic procedures were conducted at room temperature (22 - 25 G) .
15
A DEAE-cellulose column (5 x 15 cm) was equilibrated with 0.01 M
Tris-HCl, pH 7,4. The column was developed at a constant pH (7.4),
first by washing it with the starting buffer (0.01 M Tris-HCl) and then
carrying out a stepwise elution with a KCl gradient ranging from 0.0 -
1.0 M to elute the APase. Tubes having the highest specific activity
were pooled, concentrated, and further purified on a Sephadex G-200
column (1.5 x 30 cm) using 0.01 M Tris-HCl containing 0.05 M MgCl2 and
0.015 M NaCl, pH 7.5, as the eluent.
Fractions were collected by a Buchler automatic fraction collector
which was connected to a Uvicord II monitor (LKB) which measured the
absorbance of protein molecules in the fractions at 280 nm. The enzyme
activity and protein concentration of the fractions were determined and
the values plotted.
Molecular Weight Determination by
Sephadex Gel Filtration
The molecular weight determination of the native enzyme was per¬
formed on a Sephadex G-200 column (1.5 x 18 cm) which was equilibrated
with 0.05 M Tris-HCl that contained 0.05 M MgCl2 and 0.015 M NaCl. The
column was operated at a flow rate of 10 ml/hr. The following compounds
were used as molecular weight standards: RNase (13,700 d), chymotrypsinogen
A (25,000 d), ovalbvimin (45,000 d), BSA (66,000 d), aldolase (158,000 d)
and gamma-globulin (170,000 d). The homogeneity of the column bed and
the void volume were determined with blue dextran 2000. Partition
coefficients (K^^ values) were determined from the relationship
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K = (V - V„) / (V^ - V)av e o' ' ' t o'
where is the elution volume, is the void volume and is the total
volume of the column.
Molecular Weight Determination by
Acrylamide Gel Electrophoresis
Polyacrylamide gel electrophoresis in the presence of sodium
dodecyl sulfate (SDS) was carried out according to the method of Weber
and Osborn (1969), with minor modifications. The standards (RNase,
chymotrypsinogen, ovalbumin, aldolase, and BSA) and the APase were all
incubated at 37 C for 2 hr in Tris-glycine buffer, pH 8 and in 1%
SDS and 1% 2-mercaptoethanol. The APase concentration was 0.4 mg/ml.
The running gel contained 12% acrylamide and 1% SDS. Electrophoresis
was performed at a constant current of 2 mA/gel.
The gels that were stained for protein were stained for 4 hr at
room temperature in an aqueous solution containing 25% 2-propanol, 10%
acetic acid and 0.05% Coomasie brilliant blue. The APase stain was
prepared just before use by combining 7.0 ml of cold 0.2 M Tris (pH 10)
with 7.0 mg of naphthol AS-MX phosphoric acid (disodium salt) and 7.0 mg
of fast blue RR salt per gel. This mixture is ground in the cold and
once the gels are placed in it, is kept in the dark. Staining is
completed within 45 min to an hour.
All gels were destained in a aqueous solution of 10% 2-propanol
and 10% acetic acid for 8 hrs. Further destaining was carried out in
10% acetic acid.
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The molecular weight of the native enzyme and its subunits was
determined by plotting the mobility versus the log of the molecular
weights of the standards. Mobility was calculated by the formula
Mobility = distance of protein migration x length before staining
length after destaining distance of dye migration
Circular Dichroism Studies
Circular dichroism measurements were performed with a Durrum-
Jasco Model SS-20 Spectropolarimeter. The spectra were taken under
constant nitrogen flush, at room temperature (22 - 25 C), and in
cylindrical quartz cells of 1-cm pathlength. The enzyme concentration
used in these experiments was 0.06 mg/ml for Fraction C and 0.073 mg/ml
for Fraction E. The urea concentrations of 1, 2 and 4 M were obtained
by adding solid urea to the enzyme solution. The buffer for all
determinations was 0.01 M Tris-HCl, pH 7.5 with 0.14 M NaCl and 0.05 M
MgCl2. Circular dichroism results are reported in terms of the molar
ellipticity [6], which is in units of degrees cm /decimole. The
calculation of % a-helix, E-pleated sheet and random coil was performed
on a Digital PDF 8/e computer.
CHAPTER IV
EXPERIMENTAL RESULTS
Purification of Alkaline Phosphatase
The procedure for the purification of murine placental alkaline
phosphatase (APase) is described in detail in the materials and
methods. A representative elution profile from the DEAE ion-exchange
step is shown in Fig, 1. The KCl concentration gradient went from
0.0 - 0.05 M. Assay of the effluent, x^hich was collected in 12 ml
fractions, showed that the peak fraction was eluted at a KCl
concentration of 0.045 M.
Figure 2 shows the elution pattern for APase obtained from a
Sephadex G-200 column after the enzyme has been partially purified by
DEAE-cellulose column chromatography. The small amount of protein
which is eluted with the peak activity fraction indicates a preparation
of high specific activity.
The results of the purification scheme for murine placental
alkaline phosphatase is given in Table 1. The basic steps employed are
homogenization of the tissue to make the crude extract, solubilization
in NP-40, and extraction with 30% cold butanol. After dialysis to
remove the butanol, the preparation was concentrated and samples were
applied to the DEAE-cellulose column. The peak fraction was further
purified by placing 2 - 3 ml aliquots on a sephadex gel column.
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Fig. 1. Fractionation of murine placental alkaline phosphatase
(APase) on a DEAE-cellulose column 1.5 x 15 cm. The
starting buffer was 0.01 M Tris-HCl, pH 7.4. Elution
was achieved by employing a KCl gradient ranging from




Fig. 2. The elution profile of solubilized murine placental APase
obtained xjith a sephadex G-200 column 1.5 x 18 cm. Tris-HCl








Treatment Activity^ Activity^ Recovery cation
Crude Extract 10,424 2,286 4.56 100.0 1.0
145,000 xq ppt 9,660 1,338 7.20 92.7 1.6
NP40 super 6,449 342 18.86 61.9 4.2
Butanol extract 3,912 52 75.80 37.5 16.62
DEAE 2,947 31 95.15 28.3 20.8
Sephadex 2,732 0.92 2,856 26.2 648
1
Enzyme units in yM pNP/minute.
^Protein in yg.
^Specific activity in enzyme unlts/mg proteln/min.
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The results presented in Table 1 show that by these procedures
a purity of approximately 650-fold is obtained when compared with the
initial crude extract. The final step of this process resulted in a
high specific activity of 2,956. We were able to get a respectable
final percent recovery of 26.2. This is slightly above the
most frequently quoted average values for percent recovery. Though
just barely above the percent recovery reported by Doellgast and Fishman
(1974) using DEAE, our value is more than double that reported by
Gomez et al, (1974) who used the technique of isoelectric focusing.
The results of a larger DEAE column using a broader KCl gradient,
which are illustrated in Fig. 3, are similar to those reported by
Doellgast and Fishman (1974). That is, we were able to obtain a peak
not found when the gradient went up to only 0.05 M (Fig. 2). The
enzymatic activity of the first major peak (Fraction C) was greater
than that of the second peak (Fraction E).
Figures 4 and 5 represent the elution profiles on sephadex of
Fractions C and E, respectively. Depicted are different effluent volumes
of 26 ml for Fraction C and 34 ml for Fraction E. Both graphs are
representations of re-chromatography on a Sephadex G-200 column. In
Fig. 5 the protein peak is eluted at the same volume as the APase
activity peak, indicating the procurement of a preparation which is
relatively pure and free of other types of proteins.
Molecular Weight and Subunit Properties
The techniques of gel electrophoresis (acrylamide) and gel
filtration (sephadex) were used to determine the presence and size of
subunits for murine placental alkaline phosphatase. Applying the
Fig. 3. Fractionation of murine placental APase on a larger
DEAE-cellulose column (5 x 15 cm) utilizing a wider
KCl gradient range. The starting buffer was 0.01 M
Tris-HCl, pH 7.4. The salt gradient was increased
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technique of gel electrophoresis, molecular weights were estimated
from a plot of mobility (cm) of standard proteins as a function of the
logarithm of their molecular weights. The calibration curve is seen in
Fig. 6 and includes as standards the dimeric and monomeric forms of
bovine serum albumin (66,500 and 33,000 d), ovalbumin (43,500 d),
and lysozyme (14,400 d). The electrophoresis of placental APase in the
presence of sodium dodecyl sulfate (SDS) resulted in a single protein
and activity band, both of which had identical mobilities. When
compared with the standards, this mobility corresponds to a molecular
weight of exactly 60,000 d as indicated by Fig. 6. In the presence
of SDS and the strong reducing agent, 2-mercaptoethanol, again a single
protein band was found. According to the curve in Fig. 6, this band
corresponded to a molecular weight of approximately 26,000 d.
Apparently this reduced APase is inactive since no activity stain was
obtained.
In order to determine the molecular weight of fractions C and E, the
technique of gel filtration was employed. Aliquots of Fractions C and E
were added separately to a Sephadex G-200 column 1.5 x 20 cm and eluted
with Tris buffer. The plot in Fig. 7 shows the extrapolated molecular
weight of Fraction C to be identical to that of gamma globulin which is
170,000 d. Represented in the same figure is a molecular weight
of approximately 68,000 d for Fraction E. Standards used in obtaining
the curve are htaman gamma globulin (170,000), aldolase (160,000),
bovine serum albumin (66,500), ovalbumin (43,500), chymotrypsinogen A
(25,000) and RNase (13,700).
Fig. 4. Re-chromatography by gel filtration of purified APase Fraction
C. The enz3nne was collected in 2 ml volumes of Tris-HCl
(0.05 M, pH 7.5).
ENZYMEU lTS/ml PROTEINCONC.{Mg/ml)
Fig. 5. Re-chromatography by gel filtration of purified APase
Fraction E. The enzyme was collected in 2 ml volumes of
Tris-HCl (0.05 M, pH 7.5).
ENZYMEU ITS/ml PROTEINCONC.{Mg/ml)
Fig. 6. Molecular weight determination of solubilized, partially
purified, reduced and unreduced APase. Acrylamide gels
contained SDS (1%) and 2-mercaptoethanol (1%).
MolecularWeight(xIO"^)
Fig. 7. Molecular weight determination of purified APase Fractions
C and E by gel filtration. Tris-HCl (0.05 M, pH 7.5) was




The value of 170,000 obtained by gel filtration for Fraction C
(Fig. 7) is identical to the molecular weight of the native enzyme
which was determined by both gel electrophoresis and gel filtration.
The molecular weight of 60,000 d determined for the unreduced APase
on acrylamide gels compares well with the value of 68,000 d reported
here (Fig. 7) for Fraction E which was determined on sephadex. Overall,
these data suggest that mouse placental APase exists in the membrane
as a dimer of approximately 170,000 d. The monomer, which is also
active, has a molecular weight of around 68,000 d. When reduced
with mercaptoethanol, fractions possessing molecular weights of
26,000 and 60,000 d were obtained.
The molecular weight of solubilized APase was determined by the
same methods used in the determination of its subunit compositions,
namely gel electrophoresis and gel filtration. The former technique
was employed with the use of an upward-flow column equilibrated with
0.05 M Tris-HCl buffer containing 0.05 M MgCl2 and 0.015 M NaCl. The
column was operated at a flow rate of 10 ml/hr. We obtained an
effluent volume for APase of 26 ml as shown in Fig. 8. This volume
was then compared with those obtained for standards of known molecular
weights. Figure 8 shows the elution of APase in relation to the
standards. Its elution volume was found to be slightly larger than that
of gamma globulin which has a molecular weight of 170,000 d and
smaller than that of aldolase which has a molecular weight of 160,000 d.
This estimated molecular weight for APase of 168,000 is in agreement
with the value of 170,000 reported previously for Fraction C (Fig. 7).
Fig. 8 Elution pattern of solubilized APase on Sephadex G-200






Figure 9 represents a calibration curve for the gel filtration
experiments. Partition coefficient (K ) values are plotted against
the logarithm of the molecular weight of the standards. The extrapolated
molecular weight of crude APase as determined by this method is approxi¬
mately 168,000 d. A similar calibration curve is found in Fig. 10.
In this graph the mobility of the proteins on acrylamide gels is plotted
versus the logarithm of the molecular weights. It, too, shows, as did
Fig. 10, an extrapolated molecular weight in the vicinity of 170,000 d.
Evaluation of Secondary Structure
by Circular Dichroism
During the purification process of this study on murine placental
APase, two fractions were found which had APase activity. After gel
filtration through Sephadex G-200 it was found that both fractions had
different elution volumes and therefore different molecular weights.
Studies were initiated using the technique of circular dichroism (CD)
determine if there were other possible differences in these two fractions.
The spectra of these two DEAE-chromatographic Fractions, namely
C and E, were taken over a range of 208 to 250 nm. This wavelength
region was chosen because of the fact that the CD in this region is
mainly a function of the secondary structure of the enzyme.
Comparison of the circular dichroism spectra of the native forms
of both APase fractions allows some evaluation of their secondary
structure. The curves for Fractions C and E are represented in Fig. 11.
Both curves are representative of protein secondary structures consisting
of a relative small amount of ct-helix and a large amount of random coil
structure.
Fig. 9. Molecular weight estimation of native solubilized placental
APase by gel filtration. The (partition coefficient)
values are for a Sephadex G-200 column 1.5 x 18 cm. The
eluent employed was 0.05 M Tris-HCl, pH 7.5, which contained
0.05 M MgCl2 and 0.015 M NaCl.
MolecularWeight(xlO‘^)
Fig. 10. Molecular weight determination of solubilized alkaline
phosphatase by SDS polyacrylamide gel electrophoresis.
Mobilities are obtained for 12% acrylamide and are plotted
as a function of the log of the molecular weight of the
standards.
MolecularWeight(xlO"^)
Fig. 11. Far UV circular dichroic spectra of native APase Fractions
C and E. The solutions contained 0.06 and 0.073 mg/ml of
enzyme, respectively, in 0.05 M Tris-HCl buffer, pH 7.5.




In our continuing efforts to characterize the two fractions it
was of interest to determine how varying concentrations of urea might
affect the conformational stability of the molecules in question,
especially since urea is known to be capable of changing the conforma¬
tional structure of proteins. Figures 12 and 13 show the influence of
varying concentrations of urea on the far-ultraviolet CD spectra of
Fractions C and E, respectively. Analysis of both spectra at all
urea concentrations reveals that a significant change occurred in the
conformational structure of murine placental APase at a minimum urea
concentration of 2 M.
Table 2 shows the percent change in [91215 APase Fractions
C and E following urea treatment. The percent changes found, 17.1
and 20.4, respectively, are suggestive of an APase molecule which has
a reasonably flexible peptide backbone.
The results in Table 3 represent a summary of experiments designed
and conducted to evaluate the effects of urea on the percent a-helix,
3-pleated sheet and random coil structure in placental alkaline
phosphatase Fractions C and E. The data show that the polypeptide
structure for both fractions in the native form consists of a very
small percent a-helix and a comparatively large amount of random coil.
The least amount of change in conformation as a result of the urea
treatment occurred in the beta-structure. The data further indicate
that no significant differences exist in the percent a-helix, 6-pleated
sheet and random coil structure in the native form of the two fractions.
*
Fig. 12. Far UV circular dichroic spectra of APase Fraction C
measured in varying concentrations of urea. The enz3mie
concentration was 0.06 mg/ml in 0.05 M Tris-HCl, pH 7.5.








Fig. 13. Far UV circular dichroic spectra of Fraction E measured
in increasing concentrations of urea. The enzyme
concentration was 0.073 mg/ml using 0.05 M Tris-HCl,
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Fraction C Fraction E
t®]215nm^ % Change t®^215nm % Change
0 -4910 0 -5742 0
1 M -4623 5.9 -5457 5.0
2 M -4360 11.2 -4910 14.5
4 M -4071 17.1 -4570 20.4
3- 2[0] in degrees cm /decimole.
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Table 3. Effects of varying urea concentrations on the CD calculated




o-Helix 6-Pleated Sheet Random Coil
C E C E C E
Native 4.0^ 7.0 18.0 19.3 77.9 73.7
1 M 3.0 6.0 17.5 18.8 79.5 75.2
2 M
. 2.0 4.0 17.2 18.1 80.8 77.9
4 M 1.0 3.0 16.6 16.7 82.4 80.3
Native enzyme treated with 1, 2 and 4 molar urea.
►
Data expressed as percent.
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Also, further evaluation and comparison of the data show that no
significant differences between fractions C and E occurred upon
treatment with increasing concentrations of urea.
CHAPTER V
DISCUSSION AND CONCLUSIONS
The biochemical properties of murine alkaline phosphatases have
been studied extensively by Metcalf et al. (1962) and Lumb and Doell
(1970). However, few if any data are available relative to the physical
properties of these enzymes. The overall objective of this study was to
determine some of the biophysical characteristics of mouse placental
APase, namely its molecular weight, subunit composition and its
secondary structure.
In order to enhance the reliability of our data the studies
were carried out with a purified enzyme- Mammalian APases have been
isolated or purified from a variety of organs, especially human
placenta (Harkness, 1968a; Sussman et al., 1968; Ghosh and Fishman,
1968). Therefore, this APase was occasionally used for comparison with
the mouse placental APase.
In our studies a comparatively high degree of purification was
achieved by subjecting the enzyme to NP-40 solubilization, butanol
extraction and chromatography on DEAE-cellulose and Sephadex G-200. A
fold purification of approximately 650 and a specific activity of nearly
3,000 are general indications of the level of purity of the enzyme
used in this study. The fold purification reported here for mouse
placental APase is similar to a fold purification of more than 1000 which
is frequently reported for the human placental APase. The appearance on
acrylamide gels of a single protein band coincident with APase activity
41
42
further supports our contention of having obtained a reasonably purified
enzyme.
The two fractions eluted from the DEAE-cellulose column have
been shown to have different molecular weights. However, the exact
reason for their differences in behavior on DEAE in response to increasing
salt concentration has to be speculative at this point. One possible
reason is that not enough work has been done relative to the factors
that account for the net charge on the enzyme, i.e., amino acid compo¬
sition and carbohydrate content.
Alkaline phosphatases are generally stable at room temperature in
neutral or slightly alkaline solutions. During the purification process
of mouse placental APase, we observed that as the level of purity
increased, the degree of stability decreased. This loss in stability
may be due to the removal of various extraneous proteins from the native
environment of the enzyme during the purification procedures. It was
also noticed that Fraction C was more stable than Fraction E.
The molecular weight analysis of the native enzyme by gel filtration
and gel electrophoresis has resulted in an estimated molecular weight
of 170,000 d. Both methods gave similar results which agree with the
value of 150,000 - 170,000 reported for various other mammalian alkaline
phosphatases. The mouse placental alkaline phosphatase is reported
in this study to be a dimer consisting of 2 subunits which are similar but
not necessarily identical. This is apparent from the molecular weight
data obtained for the monomer (68,000), and the dimer (170,000). It is
worthy of note that the molecular weight reported here for the monomer
of mouse placental APase is very close, to the molecular weight value of
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58,000 ± 500 reported by Gottlieb and Sussman (1968) for the monomeric
form of human placental APase. Our values also compare favorably with a
70,000 d molecular weight variant A reported by Ghosh and Fishman (1968),
also for human placental APase. The molecular weight reported here
for the mouse placental APase dimer (170,000 d) differs somewhat from
the molecular weight of 116,000 ± 1,000 for the human placental APase
dimer as reported by Gottlieb and Sussman (1968). This observed difference
may very well be phylogenetic in origin. It could also be due to the
methods employed in the determination of the molecular weight.
With regards to genetics, Robson and Harris (1967) have shown that
there are three common types of subunits of human placental APase which
can combine to give six electrophoretically distinguishable variants. The
coli alkaline phosphatase is a dimer of molecular weight 86,000 when
first isolated. However, Reynolds and Schlesinger (1967) found that in
the presence of excess zinc, the enz3nne formed a tetramer with a molecular
weight of 172,000 d. Thus, the existence of an additional polypeptide
chain is not necessarily uncommon or unique.
Possibly a more definitive explanation for the differences in
molecular weight of the mouse and human placental enzyme may be found in
the techniques employed during the investigation. The molecular weight
and subunit structure for the human placental APase, as reported by
Gottlieb and Sussman (1968), was done on the ultracentrifuge by sedimentation
velocity. This is generally accepted as being a better and more precise
method than that of molecular sieve. This fact is more pronounced when
molecular sieve is used to determine the molecular weight of the more
complex proteins, i.e., glycoproteins. Although the specific carbohydrate
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content has not yet been resolved for mouse placental APase, Floyd (1973)
has shown that it is a glycoprotein. Numerous investigators have shown
that glycoproteins behave anomalously during chromatography on Sephadex
(Andrews, 1965; Spiro, 1973) and acrylamide gels (Segrest et al., 1971;
Russ and Polakova, 1973). Spiro (1973) found that with Sephadex,
glycoproteins are eluted at a faster than expected rate, resulting in
a smaller elution volume and therefore an estimated molecular weight that
is higher than the true molecular weight. He suggests that this smaller
than expected elution volume is due to a greater hydration of the molecule
in solution brought about by the carbohydrate units.
Continuing with this unusual behavior of glycoproteins, Segrest
et al. (1971) and Russ and Polakova (1973) have shown that such proteins
during SDS-polyacrylamide gel electrophoresis migrate at a slower rate
than expected, that is, based on their molecular size. This again
results in an over estimation of the molecular weight. It has been
attributed to the degree of binding of SDS to the protein which itself is
dependent upon the concentration of acrylamide (Russ and Polakova, 1973).
Thus, there appears to be a strong possibility that the molecular weight
derived in this study for the native form of mouse placental APase may
not be as high as the data suggest. Consequently, our findings are to be
used only as an estimated molecular weight. Future determinations by
sedimentation velocity and viscometry will without a doubt result in a
more precise molecular weight for the native enzyme as well as its
subunits.
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Mouse placental APase appears to exist in the native state as a
dimer. Although coli APase when first isolated is a dimer, two of
these are capable of self-association and may result in the formation
of the tetramer. All studies done thus far on the human placental APase
have indicated that in its native condition it too is a dimer.
The heterogeneity found here in the molecular weights of the sub¬
units may represent variation in the carbohydrate moieties located on a
basically similar core structure. Saraswathi and Bachhawat (1966) drew
a similar conclusion following their studies with APase from sheep brain.
Recently, many other investigators have found that the microheterogeniety
seen in various APase isoenzymes can be eliminated by treating the
enz3aae with neuraminidase. This was found to be true in studies with
HeLa cell APase Isoenzymes (Spencer, 1967) as well as for the human
placental APase isoenzyme (Ghosh and Fishman, 1967). Such observations
have led to the suggestion that many of the discrepancies in the
migration of various APases may be due to the sialic acid content of a
basic core molecule.
In order to detect possible differences in conformation of
Fractions C and E, the far-UV circular dichroic spectra were taken of
the native enzyme at wavelengths ranging from 208-250 nm. Both
fractions exhibited basically the same spectral curves, differing only
in magnitude. Additional CD studies were done in an attempt to further
characterize these low-salt (C) and high-salt (E) DEAE fractions.
Urea was used to determine differences or similarities in their structural
stability.
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Four molar urea results in a 17 percent change in the molar
ellipticity, [0], for Fraction C. A 20 percent change is seen in [91215
for Fraction E at the same molar concentration of urea. Changes in
ellipticity of this magnitude as a result of treatment with urea suggest
that both fractions have a reasonably flexible peptide backbone. However,
the similarity of the degree of change in the two fractions (17 and 20
percent) suggests that in terms of structural stability, no significant
differences exist between Fractions C and E.
A computer simulation was used to determine the various combina¬
tions of ct-helix, S-pleated sheet and random coil structure found in
Fractions C and E of mouse placental APase before and following treatment
with urea.
Both Fractions, C and E, show similar responses to the urea. One
can detect a small but consistent decrease in negative ellipticity
concomitant with the increasing urea concentration. This relationship
can be interpreted as an indication of decreasing amounts of a-helix
present in the enz3niie molecule. The data presented here relative to the
percent a-helix, 0-pleated sheet and random coil further support the
idea that the two fractions are similar in secondary structure but are
not identical.
A small number of studies has been carried out on the secondary
structure of the E_^ coli APase and of the human placental APase. From
the CD spectra for coli APase, Applebury and Coleman (1969) reported
that this enzyme contained approximately 60% g-structure, about 30%
random coil and less than 10% a-helix. They expressed some surprise at
such a low value for helical content, especially when the work of Reynolds
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and Schlesinger (1969) is taken into account in which they reported a
percentage a-helix of 40.5 for the same enzyme. The latter value was
determined from optical rotatory dispersion (ORD) spectra rather than
circular dichroism. The same technique ORD was employed by Sussman and
Gottlieb (1969) to determine the percent a-helix for human placental
APase. From the ORD curves generated, they calculated the helical
content to be less than 10%. Thus, it appears that our results relative
to helicity are in excellent agreement with those reported for coli
APase and human placental APase, despite the wide phylogenetic
differences. Our data also compare favorably with the results of CD
studies done on other membrane-bound glycoproteins. In their analysis
of the spectra of various glycoproteins. Decker and Carraway (1975)
indicated that such proteins can be pictured as existing primarily in an
unordered form in dilute aqueous buffer with only small amounts of
a-helix (13-23%) present.
Trotman and Greenwood (1971) used the technique of circular
dichroism and found a progressive spectral change toward random coil
formation with increasing urea concentration using coli K-12 wild-type
alkaline phosphatase. The drastic changes observed by these authors
were not found in our studies with mouse placental APase. Their
reported shift toward a more unordered polypeptide structure seems to be
a reasonable occurrence since the helical content for the native _E. coli
wild-type enzyme was reported to be much higher (40%) than that reported
here for the mouse placental enzyme (7%). Also, this initial lesser
degree of randomization in the coli enzyme provides a greater
opportunity for change in that direction.
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Based on the similarities reported in this study between the mouse
and human placental APase as well as the previously established similari¬
ties of the human APase with tumor-associated APases reported by other
investigators, this study will help to substantiate the idea that the
mouse system can be used as a model in which to study embryonic functions
in malignant transformation.
Much work remains to be done before one can make any real conclusive
statements about the biophysical properties of murine placental alkaline
phosphatase. Once further studies have been completed, the biochemical
data can be better evaluated and a more comprehensive biological role can
be assigned to this membrane-bound enz3mie. Considering the fact that
this is an inaugural study on the biophysical properties of murine placental
APase, its real significance will be determined by the kinds and number
of research ideas that are outgrowths of its content.
CHAPTER VI
SUMMARY
1. The main objective of this study was to characterize mouse placental
alkaline phosphatase in order to determine its similarity to
some tumor-associated APases.
2. The molecular weight, subunit properties, and secondary structure
were determined for purified mouse placental APase.
3. Investigative techniques employed consisted of acrylamide gel
electrophoresis, circular dlchroism, Sephadex and DEAE-cellulose
column chromatography.
4. A comparatively high level of purity (650-fold) of APase was
achieved.
5. The molecular weight of the native enzyme is approximately 170,000 d.
In the membrane it is at least a dimer composed of two subunits of
approximately equal molecular weights (68,000 d).
6. The enzyme is active in the monomeric form as demonstrated by SDS
acrylamide gel electrophoresis in the presence of 2-mercaptoethanol.
7. Like most other mammalian APases, the secondary structure of
mouse placental APase consists of a relatively small amount of
d-helix structure (less than 10%).
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8. The similarities reported here between mouse placental APase
and other tumor-associated APases in terms of molecular weight,
subunit structure, and a-helix content suggest that the mouse
system can be used effectively as a model system for the study of
embryonic functions in malignant transformation.
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